Menu
Recruiting NCT06654635

Ultrasound Guided Rhomboid Intercostal Plane Block Versus Thoracic Erector Spinae Plane Block in Upper Abdominal Surgery

No phase Interventional Ultrasound Rhomboid Intercostal Plane Block Thoracic Erector Spinae Plane Block Upper Abdominal Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Rhomboid intercostal plane block, Erector spinae plane block, Control group.
Who it may be relevant to
Registry conditions: Ultrasound, Rhomboid Intercostal Plane Block, Thoracic Erector Spinae Plane Block, Upper Abdominal Surgery. Basic parameters: 21 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison Between Ultrasound Guided Rhomboid Intercostal Plane Block and Thoracic Erector Spinae Plane Block in Patients Undergoing Upper Abdominal Surgery: A Randomized Controlled Trial

Overview

The aim of the work is to evaluate the analgesic efficacy of ultrasound guided rhomboid intercostal plane block versus ultrasound guided thoracic erector spinae block in patients undergoing upper abdominal surgery.

Detailed description

Abdominal surgery is one of the most definitive and mainstay treatment options for abdominal pathologies in clinical practice. Acute postoperative pain is a major challenge in the postoperative period.

The improved safety and efficacy that ultrasound brings to regional anesthesia helped promote its use and realize the benefits that regional anesthesia has over general anesthesia, such as decreased morbidity and mortality, superior postoperative analgesia, cost-effectiveness, decrease postoperative complications and an improved postoperative course .

Interventions

  • Drug Rhomboid intercostal plane block
    The patients in this group will receive ultrasound -guided rhomboid intercostal plane block after induction of general anesthesia. The rhomboid intercostal block will be performed at the T6 levels, bilaterally.
  • Other Erector spinae plane block
    The patients in this group will receive ultrasound -guided Erector spinae plane block after induction of general anesthesia. Erector spinae plane block will be performed at the level of T9 bilaterally.
  • Other Control group
    No block will be performed, and patient will receive general anesthesia (GA) only.

Primary outcome measures

  • Total morphine consumption [Time frame: 24 hours postoperatively]
Secondary outcome measures (5)
  • Degree of pain [Time frame: 24 hours postoperatively]
  • Time to 1st request of rescue analgesia [Time frame: 24 hours postoperatively]
  • Heart rate [Time frame: Every 15 min till the end of surgery]
  • Mean arterial blood pressure [Time frame: Every 15 min till the end of surgery]
  • Incidence of side effects [Time frame: 24 hours Postoperatively]

Eligibility criteria

Inclusion criteria

  • Patients aged 21-65 years.
  • Both gender.
  • American Society of Anesthesiologists (ASA) classification I-II.
  • Presented for elective upper abdominal surgery.

Exclusion criteria

  • Patients refused to participate.
  • Patients with known or suspected allergy to the used medication.
  • Patients with preoperative chronic pain.
  • Patients with major cardiac, renal, respiratory, or hepatic disease.
  • Patients with potential risk of coagulopathy.
  • Obese patients with body mass index (BMI) >35.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Tanta University — Tanta

Identifiers

NCT: NCT06654635 · 36264MD87/5/23

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗